Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000000501 | SCV000220395 | likely pathogenic | Hereditary fructosuria | 2014-06-10 | criteria provided, single submitter | literature only | |
Gene |
RCV000760464 | SCV000890352 | pathogenic | not provided | 2022-09-06 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Also reported as R59X due to alternate nomenclature; This variant is associated with the following publications: (PMID: 25525159, 8299883, 8071980, 26937407, 15880727, 27604308, 20882353, 20033295, 8299892, 35398868, 18541450) |
Fulgent Genetics, |
RCV000000501 | SCV000894462 | pathogenic | Hereditary fructosuria | 2021-11-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000000501 | SCV000916436 | pathogenic | Hereditary fructosuria | 2017-11-09 | criteria provided, single submitter | clinical testing | Variant summary: The ALDOB c.178C>T (p.Arg60X) variant results in a premature termination codon, predicted to cause a truncated or absent ALDOB protein due to nonsense mediated decay, which are commonly known mechanisms for disease. This variant was found in 20/277036 control chromosomes (gnomAD) at a frequency of 0.0000722, which does not exceed the estimated maximal expected allele frequency of a pathogenic ALDOB variant (0.0044721). Multiple publications have cited the variant in affected compound heterozygote and homozygote patients. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as pathogenic. |
Invitae | RCV000000501 | SCV000964566 | pathogenic | Hereditary fructosuria | 2024-01-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg60*) in the ALDOB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDOB are known to be pathogenic (PMID: 18541450). This variant is present in population databases (rs118204429, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with hereditary fructose intolerance (PMID: 8071980, 8299883, 15880727, 20882353, 26937407). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 472). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000000501 | SCV001810254 | pathogenic | Hereditary fructosuria | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000000501 | SCV002024916 | pathogenic | Hereditary fructosuria | 2022-01-26 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002251843 | SCV002523704 | pathogenic | See cases | 2019-05-09 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PM2, PM3, PP3, PP5 |
Ambry Genetics | RCV002512606 | SCV003528888 | pathogenic | Inborn genetic diseases | 2022-04-21 | criteria provided, single submitter | clinical testing | The c.178C>T (p.R60*) alteration, located in exon 3 (coding exon 2) of the ALDOB gene, consists of a C to T substitution at nucleotide position 178. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 60. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.0085% (24/282704) total alleles studied. The highest observed frequency was 0.01% (4/35438) of Latino alleles. This alteration has been reported in multiple patients with hereditary fructose intolerance (Brooks, 1994; Santer, 2005; Davit-Spraul, 2008; Valadares, 2015; Kim, 2021). Based on the available evidence, this alteration is classified as pathogenic. |
Prevention |
RCV003407248 | SCV004113432 | pathogenic | ALDOB-related condition | 2023-05-16 | criteria provided, single submitter | clinical testing | The ALDOB c.178C>T variant is predicted to result in premature protein termination (p.Arg60*). This variant has been reported to be causative for hereditary fructose intolerance (Brooks et al. 1994. PubMed ID: 8299883; Valadares et al. 2015. PubMed ID: 26937407; Reid et al. 2016. PubMed ID: 27604308; Kim et al. 2021. PubMed ID: 33028743). Note, this is also referred to as R59op, Arg59Ter, and Arg60Ter in some literature. This variant is reported in 0.011% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-104192183-G-A). Nonsense variants in ALDOB are expected to be pathogenic. This variant is interpreted as pathogenic. |
Baylor Genetics | RCV000000501 | SCV004196071 | pathogenic | Hereditary fructosuria | 2023-10-31 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000000501 | SCV000020650 | pathogenic | Hereditary fructosuria | 1994-06-01 | no assertion criteria provided | literature only | |
Gene |
RCV000000501 | SCV000257568 | not provided | Hereditary fructosuria | no assertion provided | literature only | One of the six most common HFI variants in US and European populations including Turkey, Spain, Central Europe, France, US, and Italy | |
Natera, |
RCV000000501 | SCV001462846 | pathogenic | Hereditary fructosuria | 2020-09-16 | no assertion criteria provided | clinical testing | |
ATS em Genética Clínica, |
RCV000000501 | SCV001573831 | likely pathogenic | Hereditary fructosuria | 2021-03-18 | no assertion criteria provided | literature only |